624 Organometallics, Vol. 26, No. 3, 2007
Chen et al.
6.89 (t, J ) 7.6 Hz, 2H, ArH), 2.51 (m, 6H, CH2), 1.48 (s, 18H,
tBu), 1.18 (t, J ) 7.5 Hz, 6H, Me), 1.00 (t, J ) 7.5 Hz, 3H, Me).
13C NMR (CDCl3, 300 MHz): δ 167.4, 160.7, 146.0, 137.8, 131.0,
130.6, 130.5, 126.8, 125.8, 118.6, 118.2, 35.0, 29.4, 24.8, 20.6,
15.1, 14.6. Anal. Calcd for C34H44N2O2: C, 79.65; H, 8.65; N, 5.46.
Found: C, 79.34; H, 8.65; N, 5.34.
7.5 Hz, 2H, ArH), 7.17 (s, 1H, ArH), 6.88 (t, J ) 7.5 Hz, 2H,
ArH), 3.20 (m, 1H, CH), 2.95 (m, 2H, CH), 2.35 (s, 6H, Me), 1.19
(d, J ) 6.8 Hz, 12H, Me), 1.16 (d, J ) 7.2 Hz, 6H, Me). 13C NMR
(CDCl3, 300 MHz): 167.2, 159.5, 145.8, 135.7, 134.4, 130.0, 128.5,
126.4, 120.9, 118.7, 117.9, 28.2, 28.0, 23.8, 22.3, 14.3. Anal. Calcd
for C31H38N2O2: C, 79.11; H, 8.14; N, 5.95. Found: C, 78.93; H,
8.17; N, 5.86.
Complex 3d was prepared using the same procedure for complex
3a. A 0.060 g (0.20 mmol) sample of sodium hydride, 0.385 g
(0.75o mmol) of ligand 1d, and 1.00 g (1.44 mmol) of trans-NiCl-
(Ph)(PPh3)2 were used to give 0.811 g (yield, 83%) of yellow-brown
Complex 3f was prepared using the same procedure for complex
3a. A 0.060 g (0.20 mmol) portion of sodium hydride, 0.353 g
(0.750 mmol) of ligand 1f, and 1.00 g (1.44 mmol) of trans-NiCl-
(Ph)(PPh3)2 were used to give 0.624 g (yield, 66%) of yellow
1
crystals. H NMR (C6D6, 500 MHz): δ 7.98 (d, J ) 9.2 Hz, 2H,
1
CHdN), 7.78 (t, J ) 8.7 Hz, 12H, ArH), 7.43 (d, J ) 7.4 Hz, 2H,
ArH), 7.10 (d, J ) 7.6 Hz, 2H, ArH), 7.05-6.91 (m, 21H, ArH),
6.77 (d, J ) 7.6 Hz, 2H, ArH), 6.61 (t, J ) 7.4 Hz, 2H, ArH), 6.32
(t, J ) 7.0 Hz, 2H, ArH), 6.18 (t, J ) 7.4 Hz, 2H, ArH), 6.12 (t,
J ) 7.0 Hz, 2H, ArH), 3.51 (m, 1H, CH2), 3.08 (m, 2H, CH2),
2.68 (m, 1H, CH2), 2.51 (t, J ) 7.5 Hz, 3H, Me), 2.42 (m, 2H,
crystals. H NMR (C6D6, 500 MHz): δ 8.06 (d, J ) 9.1 Hz, 2H,
CHdN), 7.66 (m, 12H, ArH), 6.97-6.78 (m, 26H, ArH), 6.52-
6.34 (m, 9H, ArH), 4.13 (m, 1H, CH), 3.64 (m, 2H, CH), 1.50 (s,
6H, Me), 1.02-0.87 (m, 18H, Me). IR (cm-1, KBr): 3049m, 2956s,
2926m, 2865m, 1605vs, 1583s, 1561m, 1542vs, 1481m, 1466m,
1448s, 1433vs, 1376s, 1360m, 1329s, 1240m, 1217s, 1191m,
1163m, 1095s, 1083m, 1052m, 1018m, 998w, 969w, 868m, 747s,
729s, 693vs, 640w, 529s, 511s, 492m, 453w, 420w. Anal. Calcd
for C79H76N2Ni2O2P2: C, 75.02; H, 6.06; N, 2.21. Found: C, 75.26;
H, 6.32; N, 1.82.
t
CH2), 1.00 (t, J ) 7.5 Hz, 6H, Me), 0.92(s, 18H, Bu). 13C NMR
(C6D6, 300 MHz): 167.1, 166.4, 148.9,147.5, 146.3, 141.9, 137.4,
137.2, 135.1, 134.9, 133.6, 133.3, 132.4, 131.8, 131.4, 129.7, 126.1,
124.7, 124.2, 120.9, 120.4, 113.9, 34.6, 29.8, 25.8, 22.8, 15.7, 15.5.
IR (cm-1, KBr): 3046m, 3004w, 2961s, 2867m, 1601vs, 1587vs,
1563s, 1536vs, 1481m, 1461s, 1435s, 1417s, 1386s, 1337s, 1317s,
1222w, 1187s, 1144s, 1092s, 1056w, 1018w, 996w, 965w, 871m,
859w, 749s, 729s, 693vs, 530s, 511s, 490s, 450w, 438w, 421w.
Anal. Calcd for C82H82N2Ni2O2P2: C, 75.36; H, 6.32; N, 2.14.
Found: C, 75.12; H, 6.50; N, 1.98.
Synthesis of Binuclear Nickel Complex 3g. Ligand 1g was
prepared using the same procedure for ligand 1a. A 1.78 g (10.0
mmol) amount of 3-tert-butylsalicylaldehyde and 1.17 g (5.00
mmol) of 2,4,6-triisopropyl-m-phenylenediamine were used to give
2.09 g (yield, 71%) of yellow crystals. 1H NMR (CDCl3, 500
MHz): δ 8.32 (s, 2H, CHdN), 7.44 (d, J ) 7.5 Hz, 2H, ArH),
7.20 (d, J ) 7.5 Hz, 2H, ArH), 7.17 (s, 1H, ArH), 6.90 (t, J ) 7.5
Hz, 2H, ArH), 3.21 (m, 1H, CH), 2.96 (m, 2H, CH), 1.49 (s, 18H,
tBu), 1.20 (d, J ) 6.7 Hz, 12H, Me), 1.17 (d, J ) 6.9 Hz, 6H, Me).
13C NMR (CDCl3, 300 MHz): δ 167.6, 160.7, 145.6, 137.9, 135.7,
130.6, 130.5, 128.7, 120.9, 118.5, 118.2, 35.0, 29.4, 28.2, 27.9,
23.8, 22.2. Anal. Calcd for C37H50N2O2: C, 80.10; H, 9.08; N, 5.05.
Found: C, 80.12; H, 8.64; N, 4.95.
Synthesis of Binuclear Nickel Complex 3e. Ligand 1e was
prepared using the same procedure for ligand 1a. A 1.22 g (10.0
mmol) amount of salicylaldehyde and 1.17 g (5.00 mmol) of 2,4,6-
triisopropyl-m-phenylenediamine were used to give 1.83 g (yield,
1
82%) of yellow crystals. H NMR (CDCl3, 500 MHz): δ 8.32 (s,
2H, CHdN), 7.43 (t, J ) 7.4 Hz, 2H, ArH), 7.36 (d, J ) 8.1 Hz,
2H, ArH), 7.18 (s, 1H, ArH), 7.08 (d, J ) 8.1 Hz, 2H, ArH), 6.97
(t, J ) 7.4 Hz, 2H, ArH), 3.19 (m, 1H, CH), 2.94 (m, 2H, CH),
Complex 3g was prepared using the same procedure for complex
3a. A 0.060 g (0.20 mmol) sample of sodium hydride, 0.416 g
(0.750 mmol) of ligand 1g, and 1.00 g (1.44 mmol) of trans-NiCl-
(Ph)(PPh3)2 were used to give 0.821 g (yield, 81%) of yellow-brown
1.20 (d, J ) 6.9 Hz, 12H, Me), 1.17 (d, J ) 7.1 Hz, 6H, Me). 13
C
NMR (CDCl3, 300 MHz): δ 167.2, 161.4, 144.9, 136.2, 133.9,
132.5, 128.8, 121.2, 119.3, 118.3, 117.5, 28.2, 28.0, 23.7, 22.2. IR
(cm-1, KBr) ν: 3061m, 2957s, 2927m, 2784m, 1626vs, 1576s,
1495s, 1463s, 1409m, 1383w, 1316m, 1327w, 1273vs, 1242w,
1224w, 1191s, 1152s, 1115w, 1090w, 1059w, 1033m, 1013m,
992w, 947w, 908s, 887m, 816s, 756vs, 736m, 708w. Anal. Calcd
for C29H34N2O2: C, 78.70; H, 7.74; N, 6.33. Found: C, 78.64; H,
7.54; N, 6.19.
1
crystals. H NMR (C6D6, 500 MHz): δ 8.07 (d, J ) 8.9 Hz, 2H,
CHdN), 7.76 (m, 12H, ArH), 7.44-7.39 (m, 4H, ArH), 7.02-
6.93 (m, 21H, ArH), 6.63-6.59 (m, 4H, ArH), 6.33-6.17 (m, 6H,
ArH), 4.31 (m, 1H, CH), 2.95 (m, 2H, CH), 1.31(d, J ) 5.3 Hz,
t
6H, Me), 1.03(d, J ) 5.3 Hz, 12H, Me), 0.95 (s, 18H, Bu). 13C
NMR (C6D6, 300 MHz): 167.6, 166.1, 148.6, 142.1, 138.8, 137.2,
135.0, 134.9, 133.5, 132.1, 131.5, 130.4, 129.7, 127.5, 125.4, 124.6,
120.9, 120.0, 119.2, 113.9, 34.6, 30.3, 29.9, 28.6, 26.2, 25.6, 24.9,
22.5. IR (cm-1, KBr): 3049m, 3003w, 2956s, 2906m, 2876m,
1600vs, 1562m, 1536vs, 1481w, 1466m, 1436s, 1417s, 1384m,
1360w, 1338m, 1319m, 1265w, 1246w, 1224w, 1187m, 1143m,
1098s, 1057w, 1020w, 997w, 869w, 748s, 729m, 693vs, 657w,
636w, 530s, 511m, 492m. ESI-MS (m/e): 1349 (M+). Anal. Calcd
for C85H88N2Ni2O2P2: C, 75.68; H, 6.58; N, 2.08. Found: C, 75.77;
H, 6.56; N, 1.82.
Complex 3e was prepared using the same procedure for complex
3a. A 0.060 g (0.20 mmol) amount of sodium hydride, 0.332 g
(0.750 mmol) of ligand 1e, and 1.00 g (1.44 mmol) of trans-NiCl-
(Ph)(PPh3)2 were used to give 0.818 g (yield, 88%) of yellow
1
crystals. H NMR (C6D6, 500 MHz): δ 8.02 (d, J ) 8.6 Hz, 2H,
CHdN), 7.64 (m, 12H, ArH), 7.42-6.93 (m, 26H, ArH), 6.51-
6.29 (m, 11H, ArH), 4.15 (m, 1H, CH), 2.73 (m, 2H, CH), 1.35 (d,
J ) 7.1 Hz, 3H, Me), 0.94 (d, J ) 7.2 Hz, 12H, Me), 0.84 (d, J )
7.1 Hz, 3H, Me). 13C NMR (C6D6, 300 MHz): 166.6, 160.0, 148.2,
146.8, 138.3, 138.0, 134.5, 134.4, 134.0, 131.9, 131.4, 129.9, 127.8,
127.5, 125.2, 124.7, 122.8, 121.1, 119.4, 114.3, 30.0, 28.5, 26.0,
25.2, 24.8, 22.2. IR (cm-1, KBr): 3047w, 2957m, 2869w, 1606vs,
1582s, 1561m, 1531s, 1465m, 1444vs, 1374w, 1358m, 1327m,
1251w, 1199w, 1146m, 1127w, 1095m, 1057w, 1018w, 925w,
743m, 731s, 694vs, 530s, 512s, 494m, 454w. Anal. Calcd for
C77H72N2Ni2O2P2: C, 74.78; H, 5.87; N, 2.27. Found: C, 75.08;
H, 6.14; N, 2.07.
Synthesis of Binuclear Nickel Complex 3h. Ligand 1h was
prepared using the same procedure for ligand 1a. 3-Phenylsalicyl-
aldehyde (1.98 g, 10.0 mmol) and 1.17 g (5.00 mmol) of 2,4,6-
triisopropyl-m-phenylenediamine were used to give 2.12 g (yield,
1
71%) of yellow crystals. H NMR (CDCl3, 500 MHz): δ 8.38 (s,
2H, CHdN), 7.70 (d, J ) 7.4 Hz, 4H, ArH), 7.52 (d, J ) 7.5 Hz,
2H, ArH), 7.47 (t, J ) 7.5 Hz, 4H, ArH), 7.37 (t, J ) 7.4 Hz, 4H,
ArH), 7.17 (s, 1H, ArH), 7.05 (t, J ) 7.5 Hz, 2H, ArH), 3.21 (m,
1H, CH), 2.96 (m, 2H, CH), 1.12-1.17 (m, 18H, Me). 13C NMR
(CDCl3, 300 MHz): δ 167.3, 158.3, 145.5, 137.4, 135.9, 134.4,
131.8, 130.1, 129.4, 128.6, 128.2, 127.3, 121.0, 119.1, 118.7, 28.3,
28.0, 23.8, 22.3. IR (cm-1, KBr) ν: 3051w, 2960s, 2925m, 2867m,
2786w, 2718w, 1621vs, 1585s, 1526w, 1492w, 1453s, 1432s,
1383w, 1362m, 1322m, 1280m, 1220w, 1204m, 1169w, 1099s,
Synthesis of Binuclear Nickel Complex 3f. Ligand 1f was
prepared using the same procedure for ligand 1a. A 1.36 g (10.0
mmol) amount of 3-methylsalicylaldehyde and 1.17 g (5.00 mmol)
of 2,4,6-triisopropyl-m-phenylenediamine were used to give 1.81
g (yield, 77%) of yellow crystals. 1H NMR (CDCl3, 500 MHz): δ
8.31 (s, 2H, CHdN), 7.30 (d, J ) 7.5 Hz, 2H, ArH), 7.20 (d, J )